Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First-in-human trial of a new class of DNA repair inhibitors

Nov. 27, 2012

Chemokine CXCR7 receptor antagonist CCX-662 tested in glioblastoma model

Nov. 27, 2012

Second germline SUFU mutation linked to Gorlin syndrome

Nov. 27, 2012

Daiichi Sankyo presents in vitro and in vivo data for DS-7423

Nov. 27, 2012

Wnt signaling implicated in alopecia

Nov. 27, 2012

New immunoreactive protein leads to statistically significant decrease in E. muris bacterial load

Nov. 27, 2012

CLSPN gene mutations identified in glioma patients

Nov. 26, 2012

GS-432780-5 and GS-443023-6 show promise in mouse models of chronic liver injury

Nov. 26, 2012

Ligand Pharmaceuticals presents a novel HepDirect prodrug with excellent oral bioavailability

Nov. 26, 2012

Promising results presented for a novel malaria vaccine

Nov. 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...